Cosmetic cross-reference

Threonine

CAS 72-19-5

Threonine (CAS 72-19-5) is a Phase 2 pharmaceutical compound with 2 bioactivity targets and 36 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Threonine

CAS Number

72-19-5

UNII

2ZD004190S

InChIKey

AYFVYJQAPQTCCC-GBXIJSLDSA-N

ChEMBL ID

CHEMBL291747

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 2

Mid-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL291747 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 2 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	AC50	27713.21176470588 nM	34	-
-	IC50	19976.309999999998 nM	1	-

SOURCE DrugCentral 1 association

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PT	Drug AE	LLR	MedDRA
Foetal growth restriction	15	65.074	10070531

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
THREONINE	10524	SU	MTHSPL
threonine	10524	SU	MTHSPL
threonine	10524	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Threonine used for in pharmaceutical contexts?

Threonine (CAS 72-19-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Threonine?

Threonine has 36 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Foetal growth restriction, Adverse drug reaction, Anxiety, Bronchiectasis, Bronchospasm. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Threonine also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for L-Threonine with EU status "permitted".

What clinical phase is Threonine in?

Threonine is rendered with ChEMBL max phase 2.